1-3 of 3
Rachel M. Williamson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic and Environmental Determinants of Dimethylarginines and Association With Cardiovascular Disease in Patients With Type 2 Diabetes

Maike Anderssohn, Stela McLachlan, Nicole Lüneburg, Christine Robertson, Edzard Schwedhelm, Rachel M. Williamson, Mark W.J. Strachan, Ramzi Ajjan, Peter J. Grant, Rainer H. Böger, Jackie F. Price
Journal: Diabetes Care
Diabetes Care 2014;37(3):846–854
https://doi.org/10.2337/dc13-0546
Published: 11 February 2014
View article titled, Genetic and Environmental Determinants of Dimethylarginines and Association With Cardiovascular Disease in Patients With Type 2 Diabetes
Open the PDF for Genetic and Environmental Determinants of Dimethylarginines and Association With Cardiovascular Disease in Patients With Type 2 Diabetes in another window
Journal Articles

Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study

Insa Feinkohl, MSC, Marketa Keller, MSC, Christine M. Robertson, MBCHB, Joanne R. Morling, MBCHB, Rachel M. Williamson, MBCHB, Lisa D. Nee, GRAD DIP APP SCI, Stela McLachlan, PHD, Naveed Sattar, MD, Paul Welsh, PHD, Rebecca M. Reynolds, PHD, Tom C. Russ, MBCHB, Ian J. Deary, PHD, Mark W.J. Strachan, MD, Jackie F. Price, MD, on behalf of the Edinburgh Type 2 Diabetes Study (ET2DS) Investigators
Journal: Diabetes Care
Diabetes Care 2013;36(9):2779–2786
https://doi.org/10.2337/dc12-2241
Published: 13 August 2013
View article titled, Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes: <subtitle>The Edinburgh Type 2 Diabetes Study</subtitle>
Open the PDF for Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes: <subtitle>The Edinburgh Type 2 Diabetes Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study

Rachel M. Williamson, MRCP, Jackie F. Price, MD, Stephen Glancy, FRCR, Elisa Perry, MRCP, Lisa D. Nee, GRADDIPPAPPSCI, Peter C. Hayes, PHD, Brian M. Frier, MD, Liesbeth A.F. Van Look, MRCP, Geoffrey I. Johnston, PHD, Rebecca M. Reynolds, PHD, Mark W.J. Strachan, MD, on behalf of the Edinburgh Type 2 Diabetes Study Investigators
Journal: Diabetes Care
Diabetes Care 2011;34(5):1139–1144
https://doi.org/10.2337/dc10-2229
Published: 20 April 2011
View article titled, Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
Open the PDF for Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study in another window